# Association Between Immunohistochemical Profile and Radiographic Presentation of Breast Cancer Skeletal Metastases

**Authors:** Stanislav Rajkovic, Lazar Miceta, Bojan Petrovic, Nikola Bogosavljevic, Nemanja Jovanovic, Goran Djuricic, Ljubica Simic, Jelena Sopta, Danilo Jeremic

PMC · DOI: 10.3390/diagnostics16020281 · Diagnostics · 2026-01-16

## TL;DR

This study finds that breast cancer bone metastases with a lytic appearance are more likely to be HER2 positive and have a high Ki-67 index, which could help guide treatment.

## Contribution

The study identifies HER2 positivity and Ki-67 index as novel predictors of lytic skeletal metastases in breast cancer.

## Key findings

- Lytic metastases showed significantly higher HER2 positivity compared to mixed lesions.
- A Ki-67 index cutoff of 25 had high sensitivity and specificity for predicting lytic metastases.
- No significant differences in ER or PR expression were found between lytic and mixed metastases.

## Abstract

Background/Objectives: Understanding the biological factors that drive the behavior and clinical presentation of breast cancer (BC) skeletal metastases (SM) is critical for improving diagnostic accuracy and guiding treatment strategies. However, evidence regarding the immunohistochemical (IHC) profiles of SM and their association with radiographic characteristics and clinical features remains limited. This study aimed to evaluate the relationship between estrogen receptor (ER), progesterone receptor (PR), HER2 receptor status, and Ki-67 proliferation index with the radiographic presentation of SM in patients with BC. Methods: A total of 185 SM samples from individual BC patients were analyzed. IHC expressions of ER, PR, HER2, and Ki-67 were determined for each sample. Clinical and radiological data were retrieved from medical records. IHC profiles were compared between metastases demonstrating purely lytic versus mixed radiographic patterns. Results: Of the 185 cases, 66 exhibited a lytic pattern, and 119 demonstrated a mixed pattern. Lytic metastases showed a significantly higher rate of HER2 positivity compared with mixed lesions. The Ki-67 index was also significantly higher in lytic metastases, with a cutoff value of 25 yielding a sensitivity of 92.98% and specificity of 89.84% (positive likelihood ratio 9.16; negative likelihood ratio 0.08). No significant differences were observed between groups in ER or PR expression. Conclusions: SM from BC with a lytic radiographic presentation are more likely to exhibit HER2 positivity and a Ki-67 index above 25. Assessing the IHC status of SM may help identify patients at elevated risk for skeletal complications, including pathological fracture, and may support more tailored surgical and systemic treatment planning.

## Linked entities

- **Proteins:** EREG (epiregulin), PGR (progesterone receptor), ERBB2 (erb-b2 receptor tyrosine kinase 2), Mki67 (antigen identified by monoclonal antibody Ki 67)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** ESR1 (estrogen receptor 1) [NCBI Gene 2099] {aka ER, ESR, ESRA, ESTRR, Era, NR3A1}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, PGR (progesterone receptor) [NCBI Gene 5241] {aka NR3C3, PR}
- **Diseases:** BC (MESH:D001943), SM (MESH:D009362), pathological fracture (MESH:D005598)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12839737/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12839737/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12839737/full.md

---
Source: https://tomesphere.com/paper/PMC12839737